← SynDRA
NVP-BHG712
SynDRA canonical compound SYN0086739 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | EPHB4 |
|---|
| Mechanism of action | Ephrin inhibitor |
|---|
All known targets
- EPHB4
- EPHA2
- SAMHD1
- TBC1D15
Mechanisms of action (all sources)
- Ephrin inhibitor
- EPHA2 INHIBITOR
- EPHB4 INHIBITOR
- SAMHD1 INHIBITOR
- TBC1D15 BINDER
Cross-references
Synonyms
- RefChem:912666
- NVP-BHG 712
- BHG712
- BHG 712
- N86NEM4R7Q
- DXH
- UNII-N86NEM4R7Q
- MLS006011050
- NVP-BHG712?
- orb1300847
- SCHEMBL4699731
- SCHEMBL29358745
- SCHEMBL29380618
- CHEBI:91447
- GTPL14226
- EX-A160
- GLXC-05462
- HMS3655D10
- HMS3672C11
- HMS3747I03
- NVP-BHG 712 [WHO-DD]
- BHG 712; NVP-BHG712
- HY-13258A
- NSC820799
- NSC820919
- s2202
- AKOS027301529
- CCG-269716
- NSC-820799
- NSC-820919
- SB16586
- SDCCGSBI-0654399.P001
- NCGC00249391-01
- NCGC00249391-10
- AC-32065
- BS-18262
- SMR004702842
- NVP-BHG712, >=98% (HPLC)
- CS-0094280
Look up NVP-BHG712 in the interactive SynDRA portal →